Skip to content

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Multimodal Assessment of the Inflammatory Atheromatous Plaque : Comparison Between 68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, MRI AND US

Status
Terminated
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01608516
Enrollment
20
Registered
2012-05-31
Start date
2012-04-01
Completion date
2026-07-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atheromatous Plaques, Carotid Artery Diseases, Inflammation

Keywords

PET/CT, 68Ga-NODAGA-RGD, 18F-FDG, MRI, US ultrasound, inflammatory atheromatous plaque, endarterectomy

Brief summary

The present study aims at assessing the ability of 68Ga-NODAGA-RGD PET/CT for the detection of inflammatory atheromatous plaques in the carotid arteries, compared to 18F-FDG PET/CT, MRI and US and to determine the contribution of each imaging technique. Current gold standard for inflammation is histopathology. Hypothesis : 68Ga-NODAGA-RGD might give a better initial evaluation of patients with atheromatous plaques in the carotid artery eligible for endarterectomy.

Detailed description

Patients with indication for endarterectomy will be presented the present protocol. If inclusion criteria are fulfilled, patients will have a 18F-FDG PET/CT + carotid US performed 6 to 2 days before endarterectomy and 68Ga-NODAGA-RGD PET/CT + MRI performed the day before endarterectomy. Histopathological sample will be analyzed to measure plaque inflammation. All imaging results and histopathology results will be pooled and compared.

Interventions

200 MBq 68 Ga-NODAGA-RGD will be administered i.v. and images centred on the carotid area acquired

Sponsors

University of Lausanne Hospitals
Lead SponsorOTHER
Swiss Heart Foundation
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* age \<= 85 years * Karnofsky \>= 80% * patient with indication ofr carotid endarterectomy * signed consent form

Exclusion criteria

* indication for surgery other than endarterectomy \<14 days * contraindication to surgery * contraindication to MRI * contraindication to gadolinium injection (stage 4/5 kidney insufficiency, GFR\<30ml/min/1.73m2) * pregnancy, breastfeeding * lack of discernment

Design outcomes

Primary

MeasureTime frameDescription
Comparison of each method of imaging for the detection of inflammatory atheromatous plaquesWithin1 month of endarterectomyThe potential of each of the methods of imaging for the detection of inflammatory atheromatous plaques will be compared. For that purpose, the capacity of every criterion of primary assessment to determine the presence of an unstable plaque will be studied compared with the histopathological sample.

Secondary

MeasureTime frameDescription
Comparison of AUC of the imaging methodsWithin1 month of endarterectomyA comparison of the AUC will be realized to determine the superiority of a method compared with the other one, by a non parametric test comparing AUC , ROC curves respectively.
Analysis of histopathological sample of endarterectomyWithin1 month of endarterectomyThe histopathological analysis will be the degree of local inflammation estimated by the macrophagic infiltration as well as the degree of neovascularization.

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORJohn O. Prior, PhD, MD

Lausanne University Hospitals

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026